Gemmer Asset Management LLC Crispr Therapeutics Ag Transaction History

Gemmer Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$43.23 - $73.83 $518 - $885	-12 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$70.09 - $111.29 $911 - $1,446	-13 Reduced 52.0%	12 $1,000
Q1 2021 Apr 20, 2021	SELL	$110.72 - $210.04 $27,015 - $51,249	-244 Reduced 90.71%	25 $3,000
Q4 2020 Jan 28, 2021	BUY	$79.67 - $173.23 $17,447 - $37,937	219 Added 438.0%	269 $41,000
Q3 2020 Oct 21, 2020	SELL	$78.5 - $100.64 $1,962 - $2,516	-25 Reduced 33.33%	50 $4,000
Q2 2020 Jul 31, 2020	SELL	$38.5 - $76.05 $1,925 - $3,802	-50 Reduced 40.0%	75 $6,000
Q1 2020 May 01, 2020	BUY	$33.68 - $62.53 $4,210 - $7,816	125 New	125 $5,000
Q1 2019 Apr 17, 2019	SELL	$28.02 - $40.87 $5,604 - $8,173	-200 Closed	0 $0
Q3 2018 Oct 12, 2018	BUY	$44.35 - $65.71 $8,870 - $13,141	200 New	200 $9,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.